COMBINING PRIME-BOOST ANTI-TUMOUR VACCINATION WITH DEBULKING SURGERY FOR THE TREATMENT OF MALIGNANT MESOTHELIOMA

被引：0
|
作者：
Fisher, Scott [1 ]
Cleaver, Amanda [1 ]
Khong, Andrea [1 ]
Connor, Theresa [1 ]
Wylie, Ben [1 ]
Lakhiani, Daphne [1 ]
Robinson, Bruce [1 ]
Lake, Richard [2 ]
机构：
[1] Univ Western Australia, Nedlands, WA 6009, Australia
[2] Univ Western Australia, Natl Ctr Asbestos Related Dis, Nedlands, WA 6009, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
immunotherapy; Cancer Vaccine; Regulatory T cells; surgery;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.04-001
引用
收藏
页码：S457 / S457
页数：1
相关论文
共 18 条
  • [1] Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy
    Ilett, E.
    Kottke, T.
    Thompson, J.
    Rajani, K.
    Zaidi, S.
    Evgin, L.
    Coffey, M.
    Ralph, C.
    Diaz, R.
    Pandha, H.
    Harrington, K.
    Selby, P.
    Bram, R.
    Melcher, A.
    Vile, R.
    GENE THERAPY, 2017, 24 (01) : 21 - 30
  • [2] Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy
    E Ilett
    T Kottke
    J Thompson
    K Rajani
    S Zaidi
    L Evgin
    M Coffey
    C Ralph
    R Diaz
    H Pandha
    K Harrington
    P Selby
    R Bram
    A Melcher
    R Vile
    Gene Therapy, 2017, 24 : 21 - 30
  • [3] PRIME-BOOST VACCINATION FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER
    Niavarani, Seyedeh-Raheleh
    Lawson, Christine
    Tai, Lee-Hwa
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A506 - A506
  • [4] The effect of anti-tumour necrosis factor α treatment on the antibody response to influenza vaccination
    Gelinck, L. B. S.
    van der Bijl, A. E.
    Beyer, W. E. P.
    Visser, L. G.
    Huizinga, T. W. J.
    van Hogezand, R. A.
    Rimmelzwaan, G. F.
    Kroon, F. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (05) : 713 - 716
  • [5] Entecavir treatment combined with DNA vaccine and recombinant fowlpox virus "prime-boost" vaccination for chronic hepatitis B virus infection
    Feng, Feng
    Teoh, Chee Quin
    Boyle, David
    Jilbert, Allison
    VACCINE, 2008,
  • [6] Anti-tumour activity of deer growing antlers and its potential applications in the treatment of malignant gliomas
    Louis Chonco
    Tomás Landete-Castillejos
    Gemma Serrano-Heras
    Martina Pérez Serrano
    Francisco Javier Pérez-Barbería
    Carlos González-Armesto
    Andrés García
    Carlos de Cabo
    Jose Manuel Lorenzo
    Chunyi Li
    Tomás Segura
    Scientific Reports, 11
  • [7] Anti-tumour activity of deer growing antlers and its potential applications in the treatment of malignant gliomas
    Chonco, Louis
    Landete-Castillejos, Tomas
    Serrano-Heras, Gemma
    Serrano, Martina Perez
    Perez-Barberia, Francisco Javier
    Gonzalez-Armesto, Carlos
    Garcia, Andres
    de Cabo, Carlos
    Lorenzo, Jose Manuel
    Li, Chunyi
    Segura, Tomas
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] COMBINED GEMCITABINE AND ANTI-CTLA4 THERAPY TO TARGET RESIDUAL TUMOUR FOLLOWING PARTIAL DEBULKING SURGERY IN A MOUSE MESOTHELIOMA MODEL
    Khong, Andrea
    Salmons, Joanne
    Lake, Richard
    Robinson, Bruce
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S776 - S776
  • [9] A heterologous prime-boost vaccination strategy combining a Listeria and DNA-based vaccine encoding prostatic acid phosphatase (PAP) elicits a strong antigen-specific, anti-tumor response
    Johnson, Laura
    Brockstedt, Dirk
    Hanson, Bill
    Leong, Meredith
    Lauer, Peter
    McNeel, Douglas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [10] Intra-Lymph Node Prime-Boost Vaccination against Melan A and Tyrosinase for the Treatment of Metastatic Melanoma: Results of a Phase 1 Clinical Trial
    Ribas, Antoni
    Weber, Jeffrey S.
    Chmielowski, Bartosz
    Comin-Anduix, Begonya
    Lu, David
    Douek, Michael
    Ragavendra, Nagesh
    Raman, Steve
    Seja, Elizabeth
    Rosario, Darlene
    Miles, Sabrina
    Diamond, David C.
    Qiu, Zhiyong
    Obrocea, Mihail
    Bot, Adrian
    CLINICAL CANCER RESEARCH, 2011, 17 (09) : 2987 - 2996
12